Disclosure 0001539937-26-000012-2

SEC FORM 4

$588,737.94

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Disposition (code F) of 12,642 shares at $46.57 per share.

Reporting Person Khattar Jack A. · Officer Title President, CEO · Transaction Code F

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001539937-26-000012 · filed 2026-08-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "SUPERNUS PHARMACEUTICALS, INC. (SUPN)." Disclosed 2026-08-14. https://desqlong.com/cards/0001539937-26-000012-2 (retrieved 2026-09-26).